Document is current
Any future updates will be listed below
-
Authors
Cavalcante, Isadora P.
Berthon, Annabel
Fragoso, Maria C.
Reincke, Martin https://orcid.org/0000-0002-9817-9875
Stratakis, Constantine A. https://orcid.org/0000-0002-4058-5520
Ragazzon, Bruno https://orcid.org/0000-0001-9476-4973
Bertherat, Jérôme https://orcid.org/0000-0003-2551-3008
- License Information
-
More Information
Article History
Accepted: 30 June 2022
First Online: 3 August 2022
Competing interests
: J.B. has received grants to his institution from Novartis, HRA Pharma and Recordati, and personal honoraria for consulting, lectures and meeting attendance from Novartis, Corcept, HRA Pharma and Recordati. C.A.S. holds patents on PRKAR1A, PDE11A and GPR101 function; he has also received support from ELPEN, Pfizer, Sandoz and Lundbeck pharmaceuticals. M.R. has received personal honoraria for consulting, lectures and advisory board membership from Novartis, Recordati, HRA Pharma, Crinetics and Ipsen. The other authors declare no competing interests.
